Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Breast

Explore clinical trials studying Neoplasms, Breast. Study availability and eligibility vary by location and protocol.

51 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Neoplasms, Breast trial results

Completed

A Dose-escalation Vaccine Trial in HER2-overexpressing Patients With High-risk Breast Cancer

NCT00058526

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
Locations
  • GSK Investigational Site Boca Raton, Florida, United States
  • GSK Investigational Site Buffalo, New York, United States
  • GSK Investigational Site Charlotte, North Carolina, United States
  • GSK Investigational Site Seattle, Washington, United States
View all 17 locations
View Trial Details
Completed

Lapatinib In Chemotherapy-Naive Or Metastatic Breast Cancer

NCT00089999

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
Locations
  • GSK Investigational Site Hollywood, Florida, United States
  • GSK Investigational Site Santiago, Región Metro de Santiago, Chile
  • GSK Investigational Site Santiago, Región Metro de Santiago, Chile
  • GSK Investigational Site Santiago, Región Metro de Santiago, Chile
View all 31 locations
View Trial Details
Completed

Lapatinib +/- Trastuzumab In Addition To Standard Neoadjuvant Breast Cancer Therapy.

NCT00524303

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
Locations
  • GSK Investigational Site Fountain Valley, California, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Denver, Colorado, United States
  • GSK Investigational Site Hudson, Florida, United States
View all 23 locations
View Trial Details
Completed

Letrozole In Combination With Lapatinib In Neoadjuvant Treatment Of Early Breast Cancer

NCT00422903

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
Locations
  • GSK Investigational Site Brindisi, Apulia, Italy
  • GSK Investigational Site Carpi (MO), Emilia-Romagna, Italy
  • GSK Investigational Site Forlì, Emilia-Romagna, Italy
  • GSK Investigational Site Modena, Emilia-Romagna, Italy
View all 14 locations
View Trial Details
Completed

Neoadjuvant Study With Chemotherapy, Lapatinib And Trastuzumab In Breast Cancer

NCT00429299

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
Locations
  • GSK Investigational Site Berlin, State of Berlin, Germany
  • GSK Investigational Site Brindisi, Apulia, Italy
  • GSK Investigational Site Carpi (MO), Emilia-Romagna, Italy
  • GSK Investigational Site Forlì, Emilia-Romagna, Italy
View all 17 locations
View Trial Details
Completed

Lapatinib In Combination With Trastuzumab Versus Lapatinib Monotherapy In Subjects With HER2-positive Metastatic Breast Cancer

NCT00320385

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
Locations
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Sedona, Arizona, United States
  • GSK Investigational Site Highland, California, United States
  • GSK Investigational Site Sacramento, California, United States
View all 145 locations
View Trial Details
Completed

Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Advanced Or Metastatic Breast Cancer

NCT00347919

Conditions
Breast Diseases, Breast Neoplasms, Neoplasm Metastasis, +8 more
Locations
  • GSK Investigational Site Jonesboro, Arkansas, United States
  • GSK Investigational Site Alhambra, California, United States
  • GSK Investigational Site Bakersfield, California, United States
  • GSK Investigational Site Fullerton, California, United States
View all 84 locations
View Trial Details
Completed

Study Of Lapatinib In Patients With Relapsed Or Refractory Inflammatory Breast Cancer

NCT00105950

Conditions
Breast Diseases, Breast Neoplasms, Inflammatory Breast Neoplasms, +5 more
Locations
  • GSK Investigational Site Miami, Florida, United States
  • GSK Investigational Site Chicago, Illinois, United States
  • GSK Investigational Site Zion, Illinois, United States
  • GSK Investigational Site Bethesda, Maryland, United States
View all 27 locations
View Trial Details

Related conditions